Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells

International Journal of Oncology

Volumn 32, Issue 5, 2008, Pages 1085-1090

  Sigstedt, Sophia C ^a   Hooten, Carla J ^a   Callewaert, Manika C ^a   Jenkins, Aaron R ^a   Romero, Anntherese E ^a   Pullin, Michael J ^a   Kornienko, Alexander ^a   Lowrey, Timothy K ^b   Van Slambrouck, Severine ^a   Steelant, Wim F A ^a  

^a NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Breast cancer; Growth; Invasion; Prostate cancer; Taraxacum officinale

Indexed keywords

COLLAGEN TYPE 1; DANDELION EXTRACT; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; PLANT EXTRACT; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MMP2 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; PROTEINASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CONTROLLED STUDY; DANDELION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLOWER; HUMAN; HUMAN CELL; PLANT LEAF; PLANT ROOT; PRIORITY JOURNAL; PROSTATE CANCER; BREAST TUMOR; CELL MOTION; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLOWERS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; PROTEIN KINASE INHIBITORS; SRC-FAMILY KINASES; TARAXACUM;

EID: 45849097635     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.5.1085     Document Type: Article

References (32)

1. Frawley D and Lad V: The Yoga of Herbs. 2nd edition. Lotus Press, 2001.
2. Foster S and Johnson R: Desk Reference to Nature's Medicine. National Geographic Society, 2006.
3. Sweeney B, Vora M, Ulbricht C and Basch E: Evidence-based systematic review of dandelion (Taraxacum officinale) by natural standard research collaboration. J Herb Pharmacother 5: 79-93, 2005.
4. Blumenthal M: The complete German Commission E monographs: therapeutic guide to herbal medicines. American Botanical Council, Austin, 1998.
5. Takasaki M, Konoshima T, Tokuda H, Masuda K, Arai Y, Shiojima K and Ageta H: Anti-carcinogenic activity of Taraxacum plant I. Biol Pharm Bull 22: 602-605, 1999.
6. Takasaki M, Konoshima T, Tokuda H, Masuda K, Arai Y, Shiojima K and Ageta H: Anti-carcinogenic activity of Taraxacum plant II. Biol Pharm Bull 22: 606-610, 1999.
7. Choi JH, Shin KM, Kim NY, Hong JP, Lee YS, Kim H J, Park HJ and Lee KT: Taraxinic acid, a hydrolysate of sesquiterpene lactone glycoside from the Taraxacum coreanum NAKAI, induces the differentiation of human acute promyelocytic leukemia HL-60 cells. Biol Pharm Bull 25: 1446-1450, 2002.
8. Hata K, Ishikawa K, Hori K and Konishi T: Differentiation-inducing activity of lupeol, a lupine-type triterpene from Chinese dandelion root (Hokouei-kon), on a mouse melanoma cell line. Biol Pharm Bull 23: 962-967, 2000.
9. Koo HN, Hong SH, Song BK, Kim CH, Yoo YH and Kim HM: Taraxacum officinale induces cytotoxicity through TNF-alpha and IL-1alpha secretion in Hep G2 cells. Life Sci 74:1149-1157, 2004.
10. Romijn JC, Verkoelen CF and Schroeder FH: Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. Prostate 12: 99-110, 1988.
11. Bracke ME, Van Larebeke NA, Vyncke BM and Mareel MM: Retinoic acid modulates both invasion and plasma membrane ruffling of MCF7 human mammary carcinoma cells in vitro. Br J Cancer 63: 867-872, 1991.
12. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC and Chung LW: Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54: 2577-2581, 1994.
13. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S and Chung LW: LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44: 91-103, 2000.
14. Skehan P, Stroeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
15. Steelant WF, Goeman JL, Philippe J, Oomen LC, Hilkens J, Krzewinski-Recchi M-A, Huet G, Van der Eycken J, Delannoy P, Bruyneel EA and Mareel MM: Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl-glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro. Int J Cancer 92: 527-536, 2001.
16. Bracke ME, Boterberg T, Bruyneel EA and Mareel MM: Collagen invasion assay. In: Metastasis Research Protocols. Brooks S and Schumacher U (eds). Humana Press, Totowa, pp 81-89,2001.
17. Brown PD, Levy AT, Margulies IM, Liotta LA and Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184-6191, 1990.
18. Newmann DJ and Cragg GM: Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477, 2007.
19. Sriram D, Yogeeswari P, Thirumurugan R and Bal TR: Camptothecin and its analogues: a review on their chemotherapeutic potential. Nat Prod Res 19: 393-412, 2005.
20. Huang KC: The Pharmacology of Chinese Herbs. 2nd edition. CRC Press, Boca Raton, 1999.
21. Zhang CH, Mei XG, Liu L and Yu LJ: Enhanced paclitaxel production induced by the combination of elicitors in cell suspension cultures of Taxus chinensis. Biotechnol Lett 22: 1561-1564, 2000.
22. Roberts PJ and Der CJ: Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310, 2007.
23. Schutz K, Carle R and Schieber A: Taraxacum: a review on its phytochemical and pharmacological profile. J Ethnopharmacol 107: 313-323, 2006.
24. Lambert JD, Hong J, Yang GY, Liao J and Yang CS: Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 81:284-291, 2005.
25. John A and Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23, 2001.
26. Van Slambrouck S and Steelant WFA: Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells. Biochem J 401: 689-699, 2007.
27. Jin UH, Lee JY, Kang SK, Kim JK, Park WH, KIM JG, Moon SK and KIM CH: A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metallo-proteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. Life Sci 77: 2760-2769, 2005.
28. Lansky EP, Harrison G, Froom JP and Jiang WG: Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest New Drugs 23: 121-122, 2005.
29. Ovesna Z, Vachalkova A and Horvathova K: Taraxasterol and beta-sitosterol: new naturally compounds with chemoprotective/ chemopreventive effects. Neoplasma 51:407-414, 2004.
30. Eisenbrand G, Hippe F, Jakobs S and Muehlbeyer S: Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J Cancer Res Clin Oncol 130: 627-635, 2004.
31. Huang Q, Shen HM and Ong CN: Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway. Cell Mol Life Sci 62: 1167-1175, 2005.
32. Huang Q, Shen HM, Shui G, Wenk MR and Ong CN: Emodin inhibits tumor cell adhesion through disruption of the membrane lipid Raft-associated integrin signaling pathway. Cancer Res 66: 5807-5815, 2006.